MedPath
FDA Approval

Linezolid

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 18, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Linezolid(100 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Annora Pharma Private Limited

American Health Packaging

650980746

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Linezolid

Product Details

NDC Product Code
60687-754
Application Number
ANDA211813
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 18, 2023
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIEDInactive
Code: K679OBS311Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
AMMONIUM GLYCYRRHIZATEInactive
Code: 3VRD35U26CClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4Class: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
LinezolidActive
Code: ISQ9I6J12JClass: ACTIBQuantity: 100 mg in 5 mL
© Copyright 2025. All Rights Reserved by MedPath